Edition:
United States

Charles River Laboratories International Inc (CRL.N)

CRL.N on New York Stock Exchange

141.13USD
19 Feb 2019
Change (% chg)

$0.27 (+0.19%)
Prev Close
$140.86
Open
$139.91
Day's High
$141.95
Day's Low
$139.60
Volume
127,108
Avg. Vol
99,748
52-wk High
$141.95
52-wk Low
$101.58

Chart for

About

Charles River Laboratories International, Inc. is an early-stage contract research company. The Company is engaged in laboratory animal medicine and science (research model technologies) and develop a portfolio of discovery and safety assessment services, both good laboratory practice (GLP) and non-GLP, which supports its... (more)

Overall

Beta: 0.93
Market Cap(Mil.): $5,230.56
Shares Outstanding(Mil.): 47.59
Dividend: --
Yield (%): --

Financials

  CRL.N Industry Sector
P/E (TTM): 29.01 69.44 33.70
EPS (TTM): 3.79 -- --
ROI: 7.94 8.92 14.45
ROE: 20.38 10.08 15.96

Cancer center CEO leaves Merck board after disclosure scandal

NEW YORK The chief executive of Memorial Sloan Kettering Cancer Center, Craig Thompson, resigned from the boards of drugmaker Merck & Co Inc and lab services firm Charles River Laboratories International Inc on Tuesday, following media investigations about the U.S. center's ties to the pharmaceutical industry.

Oct 02 2018

UPDATE 1-Cancer center CEO leaves Merck board after disclosure scandal

NEW YORK, Oct 2 The chief executive of Memorial Sloan Kettering Cancer Center, Craig Thompson, resigned from the boards of drugmaker Merck & Co Inc and lab services firm Charles River Laboratories International Inc on Tuesday, following media investigations about the U.S. center's ties to the pharmaceutical industry.

Oct 02 2018

Earnings vs. Estimates